Martijn Simons

523 total citations
15 papers, 383 citations indexed

About

Martijn Simons is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Martijn Simons has authored 15 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Martijn Simons's work include Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Genomics and Rare Diseases (3 papers). Martijn Simons is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Genomics and Rare Diseases (3 papers). Martijn Simons collaborates with scholars based in Netherlands, United States and Taiwan. Martijn Simons's co-authors include Gilbert Vassart, Pascal Soularue, Jean‐Claude Meunier, Françoise Liners, Marc Parmentier, Catherine Mollereau, Jasmine Parma, Q. Dong, Michael Ricketts and Luc Mercken and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and BMC Cancer.

In The Last Decade

Martijn Simons

14 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martijn Simons Netherlands 7 242 195 75 56 50 15 383
Marta Szyszka Poland 12 142 0.6× 63 0.3× 106 1.4× 83 1.5× 45 0.9× 32 393
Elizabeth Phillips United States 8 157 0.6× 94 0.5× 28 0.4× 97 1.7× 77 1.5× 10 378
Takeshi Makabe Japan 8 198 0.8× 174 0.9× 22 0.3× 18 0.3× 16 0.3× 26 405
S. J. Pandol United States 6 179 0.7× 204 1.0× 56 0.7× 45 0.8× 16 0.3× 11 442
Nuria Palacios Spain 11 118 0.5× 60 0.3× 51 0.7× 145 2.6× 33 0.7× 17 338
Ningxin Zeng United States 12 264 1.1× 254 1.3× 33 0.4× 43 0.8× 16 0.3× 19 548
Ratna Biswas India 10 164 0.7× 83 0.4× 32 0.4× 92 1.6× 99 2.0× 18 392
Christina Norrbom Denmark 9 212 0.9× 102 0.5× 75 1.0× 185 3.3× 122 2.4× 11 610
K. Nakagawara Japan 7 166 0.7× 102 0.5× 81 1.1× 23 0.4× 65 1.3× 9 374
Yasuhiko Kanou Japan 13 196 0.8× 71 0.4× 49 0.7× 74 1.3× 36 0.7× 17 357

Countries citing papers authored by Martijn Simons

Since Specialization
Citations

This map shows the geographic impact of Martijn Simons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martijn Simons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martijn Simons more than expected).

Fields of papers citing papers by Martijn Simons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martijn Simons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martijn Simons. The network helps show where Martijn Simons may publish in the future.

Co-authorship network of co-authors of Martijn Simons

This figure shows the co-authorship network connecting the top 25 collaborators of Martijn Simons. A scholar is included among the top collaborators of Martijn Simons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martijn Simons. Martijn Simons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Simons, Martijn, Bram Ramaekers, Valesca P. Retèl, et al.. (2024). Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy. PharmacoEconomics. 42(4). 419–434. 2 indexed citations
3.
Takeshima, Takao, et al.. (2024). Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective. PharmacoEconomics. 42(7). 811–822. 2 indexed citations
4.
Wilschut, Janneke, Martijn Simons, Bram Ramaekers, et al.. (2023). Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands. Scientific Reports. 13(1). 2349–2349. 2 indexed citations
5.
6.
7.
Simons, Martijn, Carin A. Uyl‐de Groot, Valesca P. Retèl, et al.. (2022). Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer. Value in Health. 26(1). 71–80. 13 indexed citations
8.
Simons, Martijn, Valesca P. Retèl, Bram Ramaekers, et al.. (2021). Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer. PharmacoEconomics. 39(12). 1429–1442. 17 indexed citations
9.
Simons, Martijn, Bram Ramaekers, Valesca P. Retèl, & Manuela Joore. (2021). Early cost-effectiveness model of whole genome sequencing as a molecular diagnostic test versus standard of care in locally advanced and metastatic (Stage IIIB,C/ IV) non-squamous non-small cell lung cancer. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations
10.
Simons, Martijn, Hendrik Koffijberg, Manuela Joore, et al.. (2021). Whole genome sequencing in oncology: using scenario drafting to explore future developments. BMC Cancer. 21(1). 488–488. 13 indexed citations
11.
Simons, Martijn, Veerle M.H. Coupé, Manuela Joore, et al.. (2021). Early technology assessment of using whole genome sequencing in personalized oncology. Expert Review of Pharmacoeconomics & Outcomes Research. 21(3). 343–351. 7 indexed citations
12.
Simons, Martijn, Bram Ramaekers, Andrea Peeters, et al.. (2020). Observed versus modelled lifetime overall survival of targeted therapies and immunotherapies for advanced non-small cell lung cancer patients – A systematic review. Critical Reviews in Oncology/Hematology. 153. 103035–103035. 6 indexed citations
13.
Mollereau, Catherine, Martijn Simons, Pascal Soularue, et al.. (1996). Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene.. Proceedings of the National Academy of Sciences. 93(16). 8666–8670. 211 indexed citations
14.
Lebo, R V, George Cunningham, Martijn Simons, & Larry J. Shapiro. (1990). Defining DNA diagnostic tests appropriate or standard clinical care.. PubMed. 47(3). 583–90. 4 indexed citations
15.
Ricketts, Michael, Martijn Simons, Jasmine Parma, et al.. (1987). A nonsense mutation causes hereditary goitre in the Afrikander cattle and unmasks alternative splicing of thyroglobulin transcripts.. Proceedings of the National Academy of Sciences. 84(10). 3181–3184. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Szyszka Breakdown of academic impact, for papers by Elizabeth Phillips Breakdown of academic impact, for papers by Takeshi Makabe Breakdown of academic impact, for papers by S. J. Pandol Breakdown of academic impact, for papers by Nuria Palacios Breakdown of academic impact, for papers by Ningxin Zeng Breakdown of academic impact, for papers by Ratna Biswas Breakdown of academic impact, for papers by Christina Norrbom Breakdown of academic impact, for papers by K. Nakagawara Breakdown of academic impact, for papers by Yasuhiko Kanou
Rankless by CCL
2026